The Food and Drug Administration on Tuesday said a Canadian company could sell a generic version of the anticoagulant Plavix, the biggest-selling drug for , the developer of Plavix and the marketing ...

pink opioid pills Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization. (HealthDay News) — For patients aged older than 65 years with an acute ...

Bristol-Myers Squibb said generic competition on its biggest drug, Plavix, hamstrung third-quarter earnings, while a federal probe expanded to determine whether an ill-fated deal to protect the Plavix ...

NEW YORK -- A federal judge blocked sales of a generic version of the blood thinner Plavix Thursday while he considers the merits of a claim that a Canadian pharmaceutical company improperly entered ...

Shares of Bristol-Myers Squibb Co. sank more than 6 percent Tuesday as a generic drug maker disclosed it has begun selling a cheaper version of the big pharmaceutical company’s best-selling drug ...

ZURICH, Aug 6 (Reuters) - Novartis AG will sell a generic version of Sanofi-Aventis SA's Plavix blood-thinner at a discount of about 25 percent in Germany, it said on Wednesday. Novartis unit Hexal ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

Bristol-Myers Squibb Co. will ask a U.S. court to stop generic versions of its bestselling drug Plavix, four months after ousting its chief executive for bungling a deal to delay copycat versions of ...

Plavix is also given to those who have unstable angina or peripheral artery disease. Using Plavix in combination with aspirin may be more effective in preventing another heart attack, but this will ...

In addition, there were no significant differences between the drug groups in the percent of patients who died or were hospitalized for any reason; had a stroke or transient ischemic attack ; or who ...

Bristol-Myers Squibb Co. and Sanofi-Aventis on Thursday won a bid to stop Apotex Inc. from selling its cheaper generic version of the Plavix heart pill, the world’s second-biggest-selling medicine.